Befotertinib—a viable alternative in EGFR-mutant advanced NSCLC?

Jessica Menis, Jordi Remon

Résultats de recherche: Contribution à un journal › !!Comment/debate

1 Citation (Scopus)

langue originale	Anglais
Pages (de - à)	857-859
Nombre de pages	3
journal	The Lancet Respiratory Medicine
Volume	11
Numéro de publication	10
Les DOIs	https://doi.org/10.1016/S2213-2600(23)00216-3
état	Publié - 1 oct. 2023

Accès au document

@article{380f02689460498297db7bb19f208ad2,

title = "Befotertinib—a viable alternative in EGFR-mutant advanced NSCLC?",

author = "Jessica Menis and Jordi Remon",

year = "2023",

month = oct,

day = "1",

doi = "10.1016/S2213-2600(23)00216-3",

language = "English",

volume = "11",

pages = "857--859",

journal = "The Lancet Respiratory Medicine",